The Ontario government is set to spend an additional $50 million for greater access to three expensive cancer drugs, sources told the Toronto Star.
Of the three, Avastin may be the best known to Star readers thanks to a front-page story published two years ago yesterday. Reporter Tanya Talaga introduced readers to Esther Hart, a mother of one who succumbed to colon cancer in April 2007 at the age of 39.
No comments:
Post a Comment